Navigation Links
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)

- Significant Efforts to Expand Market and Prepare for Zingo Launch

Underway - - Nancy Donahue Promoted To Senior Vice President, Marketing and Sales, and

James Carr Promoted To Vice President, Marketing -

- Additional Manufacturing Capacity in China - - Details to be Presented at Investor Briefing Today at 12 p.m. Eastern

Time -

SOUTH SAN FRANCISCO, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced key elements of the company's commercialization and launch plans for Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system, to reduce pain associated with peripheral venous access procedures in children three to 18 years of age. In addition, at its noon briefing in New York City today, the company will review its ongoing efforts and plans to raise market awareness, gain hospital formulary acceptance and routine use, and build and expand manufacturing capacity, including:

-- creation of an Anesiva sales force of 15 reps and 2 district managers;

-- an agreement with Sagent Pharmaceuticals to co-promote Zingo focusing

on pharmacy and group purchase contracts;

-- the qualification of two automated manufacturing lines that will

produce commercial quantities of product;

-- availability of Zingo in commercial quantities in the second quarter

of 2008;

-- the promotions of Nancy Donahue and James Carr who will spearhead

Zingo sales and marketing efforts; and

-- a joint venture with Wanbang Pharmaceuticals, a company of Fosun

Pharmaceuticals of China to expand produ

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Doyle outlines spending for Medical College, UWM
2. Kanavas outlines new Invest Wisconsin agenda
3. UW stem cell guru outlines scientific and political future
4. Three Wisconsin approaches to technology transfer and commercialization
5. Medical College gets support to expand technology commercialization
6. Genzyme acquistion of Bone Care approved, significant impact forecast
7. A New C-Terminal GST Vector for Protein Production in S. pombe
8. Safe Production of High-Titer Retrovirus
9. Production of Full-Length, Biologically Active MEK1WT and MEK1CA
10. Yeast Protein Production System Features High Yields and One-Step Purification
11. Identification of Differentially Expressed Gene Products with the CastAway System*
Post Your Comments:
(Date:12/22/2014)... Dec. 22, 2014  ( ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... September when Vioxxs manufacturer removed the drug from the ... Drug Administration and the pharmaceutical industry faced a bumpy ... the pipeline problem, the slowdown instead of the ... In its March 2004 Critical Path report, FDA ...
... about integrating technology with patient care at the Digital ... in Madison. Academic and medical experts discussed technologies which ... installation, as well as the multiple roadblocks to successful ... the fact that technology for technology's sake is a ...
... was appointed as regional director for Region 5 of ... the representative of HHS Secretary Michael Leavitt, handling all ... , ,OBrien is the former chief of staff for ... director of public affairs for the manufacturing company IMC ...
Cached Biology Technology:Challenging times for FDA and drug companies equals IT opportunities 2Challenging times for FDA and drug companies equals IT opportunities 3Digitizing hospitals with the right tools 2Digitizing hospitals with the right tools 3Digitizing hospitals with the right tools 4
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 ... the biometrics industry as Acuity Market Intelligence reports ... may finally be open. Acuity forecasts that intensifying ... devices that incorporate biometrics will drive a global ... billion biometric devices by 2020.   ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader ... PerformTek biometric technology to industry leaders such as Intel, ... clinically validated, biometric wearable products. These products will be ... Las Vegas . ... accurate, flexible and robust – with the clinical data ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... at WEHI into a possible new cancer drug suggests ... less toxic than current chemotherapeutic drugs. , Dr David ... teams from WEHI's cancer research divisions have been assessing ... developed by US-based healthcare company, Abbott. , ...
... around the world keep a nervous eye on the spread ... Disease Organization (VIDO) has uncovered a key step in how ... team have discovered how a crucial pathway that supports the ... finding that could pave the way for new drugs and ...
... get lab results back from the doctor's office soon could ... of University of Georgia researchers has developed a diagnostic test ... RSV in 60 seconds or less. , In addition to ... issue of the journal Nano Letters ?could save lives by ...
Cached Biology News:Hope for a more effective and less toxic cancer drug 2U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication 2Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses 2Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses 3
Request Info...
... potent inhibition of RNase A-type ribonucleases Product ... of nonhuman origin that binds noncovalently and ... A, B, and C). It does not ... U2, or CL3. QIAGEN RNase Inhibitor inhibits ...
Request Info...
Biology Products: